Inhibitori topoizomeraze (Serbo-Croatian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Inhibitori topoizomeraze" in Serbo-Croatian language version.

refsWebsite

Global rank Serbo-Croatian rank

2^nd place

2^nd place

4^th place

3^rd place

1web.archive.org

1^st place

1^st place

1,684^th place

330^th place

1mercksource.com

8,363^rd place

508^th place

1landesbioscience.com

low place

low place

1,293^rd place

507^th place

4,455^th place

780^th place

cancer.gov

„Definition of topoisomerase inhibitor - NCI Dictionary of Cancer Terms”. Arhivirano iz originala na datum 2009-05-10.

doi.org

dx.doi.org

Mitscher LA (February 2005). „Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents”. Chem. Rev. 105 (2): 559–92. DOI:10.1021/cr030101q. PMID 15700957.
Fisher LM, Pan XS (2008). „Methods to assay inhibitors of DNA gyrase and topoisomerase IV activities”. Methods Mol. Med. 142: 11–23. DOI:10.1007/978-1-59745-246-5_2. PMID 18437302.
Scott Classen, Stephane Olland, and James M. Berger (2003). „Structure of the topoisomerase II ATPase region and its mechanism of inhibition by the chemotherapeutic agent ICRF-187”. PNAS 100 (19): 10629-10634. DOI:10.1073/pnas.1832879100. ^{[mrtav link]}
Cheryl L. Baird, Matthew S. Gordon, David M. Andrenyak, James F. Marecek, Janet E. Lindsley (2001). „The ATPase Reaction Cycle of Yeast DNA Topoisomerase II”. The Journal of Biological Chemistry 276: 27893-27898. DOI:10.1074/jbc.M102544200.

jbc.org

Cheryl L. Baird, Matthew S. Gordon, David M. Andrenyak, James F. Marecek, Janet E. Lindsley (2001). „The ATPase Reaction Cycle of Yeast DNA Topoisomerase II”. The Journal of Biological Chemistry 276: 27893-27898. DOI:10.1074/jbc.M102544200.

landesbioscience.com

Robinson HM, Bratlie-Thoresen S, Brown R, Gillespie DA (May 2007). „Chk1 is required for G2/M checkpoint response induced by the catalytic topoisomerase II inhibitor ICRF-193”. Cell Cycle 6 (10): 1265–7. PMID 17495539.

mercksource.com

„Dorlands Medical Dictionary:topoisomerase inhibitor”.

nih.gov

ncbi.nlm.nih.gov

Mitscher LA (February 2005). „Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents”. Chem. Rev. 105 (2): 559–92. DOI:10.1021/cr030101q. PMID 15700957.
Fisher LM, Pan XS (2008). „Methods to assay inhibitors of DNA gyrase and topoisomerase IV activities”. Methods Mol. Med. 142: 11–23. DOI:10.1007/978-1-59745-246-5_2. PMID 18437302.
Robinson HM, Bratlie-Thoresen S, Brown R, Gillespie DA (May 2007). „Chk1 is required for G2/M checkpoint response induced by the catalytic topoisomerase II inhibitor ICRF-193”. Cell Cycle 6 (10): 1265–7. PMID 17495539.

pnas.org

Scott Classen, Stephane Olland, and James M. Berger (2003). „Structure of the topoisomerase II ATPase region and its mechanism of inhibition by the chemotherapeutic agent ICRF-187”. PNAS 100 (19): 10629-10634. DOI:10.1073/pnas.1832879100. ^{[mrtav link]}

web.archive.org

„Definition of topoisomerase inhibitor - NCI Dictionary of Cancer Terms”. Arhivirano iz originala na datum 2009-05-10.